The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•7 April 2026•

1 min read

Avaí Bio to Present α-Klotho Anti-Aging Therapy Data at Annual Conference

Canadian flag, a plasma bag, and "GRIFOLS" text on an orange background with medical equipment, microscopes, and vials.

Key Facts

1Avaí Bio and Austrianova are set to present the latest data from their α-Klotho anti-aging therapy.

2The presentation will take place at the Second Annual Klotho Conference, focusing on the future of Klotho-based therapies.

3Avaí Bio is listed on the OTCQB under the ticker AVAI and develops cell-based therapies for diabetes and age-related disorders.

Avaí Bio, Inc. (OTCQB: AVAI), in collaboration with its joint venture partner Austrianova, is set to present the latest research data on their α-Klotho anti-aging therapy. The presentation will take place at the Second Annual Klotho Conference, a specialized event dedicated to the future of Klotho-based medical treatments. This data showcase aims to highlight the companies' progress in developing cell-based therapies for age-related disorders and diabetes. By presenting at such a specialized industry forum, Avaí Bio seeks to demonstrate its clinical advancements to both the scientific and investment communities. The company continues to focus its efforts on innovative biotechnology solutions that address the growing global demand for anti-aging treatments. Such presentations are often viewed as positive catalysts for biotech entities, reflecting the ongoing maturation of their research pipelines.